Age-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors

• Carey K. Anders,

  Affiliation Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina, United States of America

  ⨯
• Chaitanya R. Acharya ,

  Contributed equally to this work with: Chaitanya R. Acharya, David S. Hsu

  Affiliation Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  ⨯
• David S. Hsu ,

  Contributed equally to this work with: Chaitanya R. Acharya, David S. Hsu

  Affiliations Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina, United States of America, Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  ⨯
• Gloria Broadwater,

  Affiliation Cancer Center Biostatistics, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Katherine Garman,

  Affiliation Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  ⨯
• John A. Foekens,

  Affiliation Erasmus Medical Center, Rotterdam, The Netherlands

  ⨯
• Yi Zhang,

  Affiliation Veridex, Inc., Johnson and Johnson, San Diego, Californa, United States of America

  ⨯
• Yixin Wang,

  Affiliation Veridex, Inc., Johnson and Johnson, San Diego, Californa, United States of America

  ⨯
• Kelly Marcom,

  Affiliation Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina, United States of America

  ⨯
• Jeffrey R. Marks,

  Affiliation Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  ⨯
• Sayan Mukherjee,

  Affiliation Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  ⨯
• Joseph R. Nevins,

  Affiliation Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  ⨯
• Kimberly L. Blackwell,

  Affiliation Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina, United States of America

  ⨯
• Anil Potti

  *To whom correspondence should be addressed. E-mail: anil.potti@duke.edu

  Affiliations Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina, United States of America, Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  ⨯